Publisher: Allied Market Research
PR Title 1: The digital therapeutics market is expected to reach $7,833 million by 2025 with CAGR of 20.5%
According to new report added in Report Banana offerings, there are significant money making opportunities available in the digital therapeutics market. Companies planning to enter this market need to prepare and differentiate to maximize their return on investment.
In terms of opportunities, the digital therapeutics market is expected to grow from $1,751 million in 2017 to USD 7,833 million by 2025; it is expected to grow at a CAGR of 20.5% during the forecast period.
Increase in adoption of smartphones & tablets coupled with rise in utilization of healthcare apps is the major factor that drives the growth of the global digital therapeutics market. In addition, increasing need to control healthcare costs supplements the market growth.
Digital therapeutics is a type of treatment option, which utilizes online health technologies and digital devices to treat numerous medical conditions and help maintain health discipline.
Prominent players profiled in this report include Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Morrow Inc., Livongo Health, Propeller Health, Twine Health, Inc. (Fitbit Inc.), Canary Health, Inc., Noom Inc., Medtronic Plc, etc.
Significant Aspects of the Report and Main Highlights:
- Changing business trends in the digital therapeutics market
- Market segment analysis at different level such as application, product, sales channel, and region
- Historical and forecast size of the digital therapeutics market in terms of revenue
- Major drivers and opportunities pertaining to the digital therapeutics market
- Competitive landscape and player positioning analysis for the market
- Key product offerings by major players and business strategies adopted
- Key challenges faced by operating players in the market space
- Analysis of major risks associated with the market operations
The report helps stakeholders understand the pulse of the market and provides them with information on key drivers, restraints, challenges, and opportunities for market growth. It would also help to understand the competitors better and gain more insights to improve their position in the business.
To read more about this market please click on https://www.reportbanana.com/-digital-therapeutics-market-by-application-diabet-rpt40568.aspx
Contact Us at:
Phone: +1 469 638 2694 (US)
+31-6-82270883 (Europe)
+91-771-4288410 (Asia)
Email: [email protected]
About Report Banana
Report Banana provides syndicated as well as customized market research reports from various market research companies around the globe. Our product offerings register presence in most of the verticals such as aerospace, automotive, chemical, construction, consumer, E&E, medical, and service industries. For further information, visit www.reportbanana.com
Digital therapeutics, generally known as programming for medications has been increasing a lot of consideration because of the quantity of advantages it offers to patients that use it.
The development of the market is slung by expanding rates of interminable sicknesses, expanding accentuation on preventive human services, the need to control medicinal services uses, and included advantages offered by digital therapeutics.
Ascend in number of investors that are putting resources into the market is another factor that is quickening its development.Increasing Adoption of Advanced Treatment to Fuel the Sales of Digital Therapeutics Market With an expansion in the web use and reliance over cell phones, digital therapeutics offers simple following and observing of patients and their fundamental details without mediation.Request for a FREE Sample@ https://www.marketresearchfuture.com/sample_request/6492Major Competitive Analysis:The key players operating in the global digital therapeutics market include Proteus Digital Health, Inc., WellDoc, Inc., Omada Health Inc., 2Morrow, Inc., Propeller Health, Livongo Health, Twine Health, Inc., Noom Inc., and Canary Health, Inc.
The key players are trying to offer newer products with advanced facilities are driving growth of the global digital therapeutics market.Industry Segmentation:The digital therapeutics market is segmented based on product type, application, sales channel, and region.In terms of product type, the global digital therapeutics market is categorized into software and devices.Based on the application, the market is segmented into cardiovascular diseases, diabetes, obesity, smoking cessation, respiratory diseases, and other.Based on the sales channel, the market is segmented into B2B and B2C.Table Of Contents:Chapter 1.
Market Introduction2.1 Definition2.2 Scope Of The Study2.2.1 Research Objective2.2.2 Assumptions2.2.3 LimitationsChapter 3.
Research Methodology3.1 Introduction3.2 Primary Research3.3 Secondary Research3.4 Market Size EstimationChapter 4.
The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.On the basis of application, the digital therapeutics market is segmented into preventive and treatment/care-based applications.
On the basis of sales channel, the digital therapeutics market is segmented into B2C and B2B sales channel.
The B2B segment is estimated to command the largest share in 2016 and register the highest CAGR in the digital therapeutics market, by sales channel.
Factors such as growing awareness among providers, payers, and employers about the benefits of digital therapeutics and the growing inclination of pharmaceutical companies to integrate digital therapeutics with their drug products are driving the growth of this segment.Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.
However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market"148 - Tables186 - Pages36 - FiguresOrder a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at: https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.aspThe key strategies followed by most companies in the digital therapeutics market are agreements, collaborations, and partnerships; investments; and new product launches.
Among all growth strategies adopted by market players, agreements, collaborations, and partnerships accounted for the largest share of the overall growth strategies mapped from 2013 to 2016.
Increasing prevalence of chronic diseases such as diabetes, hypertension among others as well as the rising awareness by government agencies will increase the growth of the digital therapeutic (DTx) market.Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage and avert a broad spectrum of behavioural, mental and physical disorders.
Get More Insight About the North America Digital Therapeutic (DTx) Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-digital-therapeutics-market The digital therapeutic (DTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
To understand the analysis and the digital therapeutic (DTx) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.Digital Therapeutic (DTx) Market Scope and Market SizeThe digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel.
The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service.
The U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including digital therapeutic (DTx) productsStrategic Initiatives by Manufacturers is creating new opportunities for Players in the Digital Therapeutic (DTx) MarketThe digital therapeutic (DTx) market also provides you with detailed market analysis for every country growth in digital therapeutic (DTx) product sales, impact of advancement in the digital therapeutic (DTx) and changes in regulatory scenarios with their support for the digital therapeutic (DTx) market.
Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve.
Increasing prevalence of chronic diseases such as diabetes, hypertension among others as well as the rising awareness by government agencies will increase the growth of the digital therapeutic (DTx) market.Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage and avert a broad spectrum of behavioural, mental and physical disorders.
Get More Insight About the North America Digital Therapeutic (DTx) Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-digital-therapeutics-market The digital therapeutic (DTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
To understand the analysis and the digital therapeutic (DTx) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.Digital Therapeutic (DTx) Market Scope and Market SizeThe digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel.
The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service.
The U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including digital therapeutic (DTx) productsStrategic Initiatives by Manufacturers is creating new opportunities for Players in the Digital Therapeutic (DTx) MarketThe digital therapeutic (DTx) market also provides you with detailed market analysis for every country growth in digital therapeutic (DTx) product sales, impact of advancement in the digital therapeutic (DTx) and changes in regulatory scenarios with their support for the digital therapeutic (DTx) market.
Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve.
Most of companies are wanting to tap the services of health coaches that carry a minimum of a bachelor's level or even higher in a health sciences-related major, Visit this link for more information about: https://robkish.life/online-health-coaching-certifications/
For its amazing contribution to curb the non-communicable diseases and setting sustainable development goals, the United Nations has honoured the state of Kerala.World Health Organization director-general Tedros Adhanom Ghebreyesus declared the UN Interagency Task Force (UNIATF) award this year on prevention and control of non-communicable diseases.The award takes into account of the work in the prevention and control of NCDs, mental health and the wider NCD-related sustainable development goals (SDGs) done in 2019.Kerala Health Minister K K Shailaja was elated for getting recognized for the tireless service of the state in the health sector.She also appreciated the health workers of the state for their contribution to receive this honour.The state government mentioned how the award was for being able to launch a lifestyle disease control mechanism in Kerala.
Also, the treatment and free services were received many people in the state.
